---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-067546"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:49:30.907785+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte enters $500M at-the-market equity offering; terminates prior $270.3M ATM with Jefferies

## Summary
- Sales agreement with Leerink Partners for up to $500M in common stock via at-the-market offerings.
- Placement agent receives up to 3.00% compensation on gross proceeds from sales.
- Terminated prior sales agreement with Jefferies under which $270.3M had been sold.
- Company not obligated to sell any shares; no assurance of any sales under new agreement.

## SEC filing metadata
- accession: 0001193125-26-067546
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000119312526067546/0001193125-26-067546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000119312526067546/d259722d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-067546
- JSON: https://secwatch.observer/filing/0001193125-26-067546.json
- Plain text: https://secwatch.observer/filing/0001193125-26-067546.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.